InSilicoMinds (Ikiminds Pvt Ltd) & InSilicoTrials meet the DCGI
InSilicoTrials and InSilicoMinds (Ikiminds Pvt Ltd.) had a discussion with DCGI on AI, Modeling and Simulation advancements in India.
InSilicoTrials and InSilicoMinds (Ikiminds Pvt Ltd.) had a discussion with DCGI on AI, Modeling and Simulation advancements in India.
On September 29, 2022 Senate Bill 5002, “FDA Modernization Act 2.0” was both introduced in the Senate and passed by unanimous consent.
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved